CLINICAL_TRIALS trial_result · 2013-12-11

Clinical Trial Update: A Study of Prasugrel in Pediatric Participants With Sickle Cell Disease [Phase 2]

Phase 2 results for prasugrel in pediatric participants with sickle cell disease have been posted following the completion of the trial.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Eli Lilly and Company | Conditions: Sickle Cell Disease | Phase 2 | Status: COMPLETED | Results posted: 2013-12-11